Cargando…

Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants

BACKGROUND: Caffeine is widely used in preterm infants for apnea control. It has no effect on sleep in the only existing polysomnographic study including ten preterm infants Behavioral and polygraphic studies have conflicting results. METHODS: We studied 21 late-preterm infants at a median gestation...

Descripción completa

Detalles Bibliográficos
Autores principales: Seppä-Moilanen, Maija, Andersson, Sture, Kirjavainen, Turkka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556325/
https://www.ncbi.nlm.nih.gov/pubmed/34718352
http://dx.doi.org/10.1038/s41390-021-01794-y
_version_ 1784807051883446272
author Seppä-Moilanen, Maija
Andersson, Sture
Kirjavainen, Turkka
author_facet Seppä-Moilanen, Maija
Andersson, Sture
Kirjavainen, Turkka
author_sort Seppä-Moilanen, Maija
collection PubMed
description BACKGROUND: Caffeine is widely used in preterm infants for apnea control. It has no effect on sleep in the only existing polysomnographic study including ten preterm infants Behavioral and polygraphic studies have conflicting results. METHODS: We studied 21 late-preterm infants at a median gestational age of 36 weeks. Polysomnography was performed twice, at baseline on day 1 and on the day after the onset of caffeine treatment (20 mg/kg loading and 5 mg/kg morning maintenance dose). RESULTS: Caffeine acted short term as a breathing stimulant with reduction of apneas, improved baseline SpO(2) (p < 0.001), and decreased 95 percentile of end-tidal carbon dioxide level (p < 0.01). It also increased arousal frequency to SpO(2) desaturations of more than 5% (p < 0.001). Caffeine did not affect sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals. The median spontaneous arousal count was 18 per hour at baseline, and 16 per hour during caffeine treatment (p = 0.88). CONCLUSIONS: In late-preterm infants, caffeine has a clear short-term respiratory stimulant effect, and it increases the arousal frequency to hypoxia. However, caffeine does not appear to act as a central nervous system stimulant, and it has no acute effect on sleep quality. IMPACT: Effects of caffeine on sleep in preterm infants has previously been investigated with only one full polysomnographic study including ten preterm infants. The study showed no effect. The current study shows that caffeine acts short term as a respiratory stimulant and increases arousal frequency to hypoxia. Although a potent central nervous system (CNS) stimulant in adults, caffeine does not seem to have similar acute CNS effect in late-preterm infants. The onset of caffeine treatment has no short-term effect on sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals.
format Online
Article
Text
id pubmed-9556325
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-95563252022-10-14 Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants Seppä-Moilanen, Maija Andersson, Sture Kirjavainen, Turkka Pediatr Res Clinical Research Article BACKGROUND: Caffeine is widely used in preterm infants for apnea control. It has no effect on sleep in the only existing polysomnographic study including ten preterm infants Behavioral and polygraphic studies have conflicting results. METHODS: We studied 21 late-preterm infants at a median gestational age of 36 weeks. Polysomnography was performed twice, at baseline on day 1 and on the day after the onset of caffeine treatment (20 mg/kg loading and 5 mg/kg morning maintenance dose). RESULTS: Caffeine acted short term as a breathing stimulant with reduction of apneas, improved baseline SpO(2) (p < 0.001), and decreased 95 percentile of end-tidal carbon dioxide level (p < 0.01). It also increased arousal frequency to SpO(2) desaturations of more than 5% (p < 0.001). Caffeine did not affect sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals. The median spontaneous arousal count was 18 per hour at baseline, and 16 per hour during caffeine treatment (p = 0.88). CONCLUSIONS: In late-preterm infants, caffeine has a clear short-term respiratory stimulant effect, and it increases the arousal frequency to hypoxia. However, caffeine does not appear to act as a central nervous system stimulant, and it has no acute effect on sleep quality. IMPACT: Effects of caffeine on sleep in preterm infants has previously been investigated with only one full polysomnographic study including ten preterm infants. The study showed no effect. The current study shows that caffeine acts short term as a respiratory stimulant and increases arousal frequency to hypoxia. Although a potent central nervous system (CNS) stimulant in adults, caffeine does not seem to have similar acute CNS effect in late-preterm infants. The onset of caffeine treatment has no short-term effect on sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals. Nature Publishing Group US 2021-10-30 2022 /pmc/articles/PMC9556325/ /pubmed/34718352 http://dx.doi.org/10.1038/s41390-021-01794-y Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Research Article
Seppä-Moilanen, Maija
Andersson, Sture
Kirjavainen, Turkka
Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title_full Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title_fullStr Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title_full_unstemmed Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title_short Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
title_sort caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556325/
https://www.ncbi.nlm.nih.gov/pubmed/34718352
http://dx.doi.org/10.1038/s41390-021-01794-y
work_keys_str_mv AT seppamoilanenmaija caffeineisarespiratorystimulantwithouteffectonsleepintheshortterminlatepreterminfants
AT anderssonsture caffeineisarespiratorystimulantwithouteffectonsleepintheshortterminlatepreterminfants
AT kirjavainenturkka caffeineisarespiratorystimulantwithouteffectonsleepintheshortterminlatepreterminfants